Identification of a DNA Methylation Episignature in the 22q11.2 Deletion Syndrome
The 22q11.2 deletion syndrome (22q11.2DS) is the most common genomic disorder in humans and is the result of a recurrent 1.5 to 2.5 Mb deletion, encompassing approximately 20–40 genes, respectively. The clinical presentation of the typical deletion includes: Velocardiofacial, Di George, Opitz G/BBB...
Main Authors: | Kathleen Rooney, Michael A. Levy, Sadegheh Haghshenas, Jennifer Kerkhof, Daniela Rogaia, Maria Giovanna Tedesco, Valentina Imperatore, Amedea Mencarelli, Gabriella Maria Squeo, Eleonora Di Venere, Giuseppe Di Cara, Alberto Verrotti, Giuseppe Merla, Matthew L. Tedder, Barbara R. DuPont, Bekim Sadikovic, Paolo Prontera |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8611 |
Similar Items
-
Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome
by: Eric G. Bend, et al.
Published: (2019-04-01) -
Diagnostic Utility of Genome-Wide DNA Methylation Analysis in Mendelian Neurodevelopmental Disorders
by: Sadegheh Haghshenas, et al.
Published: (2020-12-01) -
VEGFA polymorphisms and cardiovascular anomalies in 22q11 microdeletion syndrome: a case-control and family-based study
by: JUAN FRANCISCO CALDERÓN, et al.
Published: (2009-01-01) -
Síndrome de deleção 22q11.2: compreendendo o CATCH22 22q11.2 deletion syndrome: catching the CATCH22
by: Rafael Fabiano M. Rosa, et al.
Published: (2009-06-01) -
Current perspectives on velocardiofacial syndrome
by: Saikrishna Lakkakula, et al.
Published: (2017-01-01)